Jenburkt Pharmaceuticals informs about outcome of board meeting

01 Dec 2022 Evaluate
Jenburkt Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on 01st December, 2022 has approved a proposal to buyback by the Company of up to 165242 fully paid-up equity shares of face value of INR 10 (Indian Rupees Ten only) each (“Equity Shares”) at a price not exceeding INR 702 (Indian Rupees Seven Hundred Two only) per Equity Share (the Maximum Buyback Price) payable in cash for an aggregate amount not exceeding INR 11,60,00,000 (Rupees Eleven Crore Sixty Lac only) (the Maximum Buy-back Size), from the shareholders of the Company excluding promoters, promoter group and persons who are in control of the Company, via the Open Market route through the stock exchanges mechanism; At the Maximum Buyback Price and for the Maximum Buyback Size, the indicative maximum number of Equity Shares bought back would be 165242 (Maximum Buyback Shares) which is 3.60% of the total number of paid-up Equity Shares of the Company.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

783.00 -8.80 (-1.11%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.